Serological and molecular study of Hepatitis E virus in pediatric patients in Mexico

Ann Hepatol. 2020 May-Jun;19(3):295-301. doi: 10.1016/j.aohep.2019.12.004. Epub 2019 Dec 16.

Abstract

Introduction and objectives: Cases of viral hepatitis reported in Mexico are typically identified as hepatitis A, B and C. However, unspecified cases are reported annually. Hepatitis E virus (HEV) is an emergent agent that causes a self-limiting infection that can evolve to chronic in immunosuppressed individuals. In Mexico, HEV genotype 2 is considered endemic, though it's the prevalence is not well known. Therefore, the present study was designed to determine the prevalence of HEV among patients at the "Hospital Infantil de Mexico Federico Gomez".

Materials and methods: The study included 99 patients, anti-HEV antibody (IgG and IgM) were detected by indirect ELISA and viral genome was identified using RT-PCR technique. Two PCR products of positive cases were sequenced.

Results: ELISA results were positive in 3% and 6%, for IgG and IgM respectively, 54.5% prevalence was found by PCR. Low lymphocyte count (p<0.05) and malnutrition (p<0.005) were significant factors for high PCR prevalence and could increase the possibility of infection. Two samples were sequenced and confirmed the presence of HEV genotype 3.

Conclusions: This report reveals the incidence of HEV in pediatric patients in Mexico. Moreover, the identification of HEV genotype 3 in human samples suggests a potential zoonotic risk that requires further research.

Keywords: Diagnostic; HEV; Hepatitis; Infectious disease; Pediatric patients; RT-PCR; Serology; Virus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alanine Transaminase / blood
  • Aspartate Aminotransferases / blood
  • Bilirubin / blood
  • Child
  • Cross-Sectional Studies
  • DNA, Viral / blood
  • Female
  • Genome, Viral / genetics
  • Genotype
  • Hepatitis A
  • Hepatitis A Antibodies / blood
  • Hepatitis Antibodies
  • Hepatitis B Antibodies / blood
  • Hepatitis C Antibodies / blood
  • Hepatitis E / blood
  • Hepatitis E / epidemiology*
  • Hepatitis E / immunology
  • Hepatitis E / virology
  • Hepatitis E virus / genetics*
  • Humans
  • Immunoglobulin G / immunology
  • Immunoglobulin M / immunology
  • Longitudinal Studies
  • Male
  • Mexico / epidemiology
  • RNA, Viral / blood
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction
  • Seroepidemiologic Studies
  • Viral Proteins / genetics

Substances

  • DNA, Viral
  • Hepatitis A Antibodies
  • Hepatitis Antibodies
  • Hepatitis B Antibodies
  • Hepatitis C Antibodies
  • Immunoglobulin G
  • Immunoglobulin M
  • ORF2 protein, Hepatitis E virus
  • RNA, Viral
  • Viral Proteins
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Bilirubin